Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
Status:
RECRUITING
Trial end date:
2026-03-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness and safety of Qingre Huatan formula versus placebo on preventing early neurological deterioration in patients with acute ischemic stroke within 48 hours after onset.